Frazier Life Sciences Management, L.P.
41 holdingsFiling period: 2026-06-30Current AUM: $4.21Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | MIRM | MIRUM PHARMACEUTICALS INC | 7.68M | $899.1M | $721.1M | 17.15% | -- | 2026-06-30 |
| 2 | — | NEWAMSTERDAM PHARMA COMPANY | 18.09M | $613.0M | $613.0M | 14.58% | +1.15M | 2026-06-30 |
| 3 | ERAS | ERASCA INC | 24.98M | $457.5M | $405.8M | 9.65% | +300.0K | 2026-06-30 |
| 4 | MBX | MBX BIOSCIENCES INC | 6.65M | $367.2M | $406.3M | 9.66% | -- | 2026-06-30 |
| 5 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | 9.87M | $258.9M | $232.1M | 5.52% | -- | 2026-06-30 |
| 6 | TRVI | TREVI THERAPEUTICS INC | 9.94M | $185.4M | $149.5M | 3.55% | -100 | 2026-06-30 |
| 7 | KRYS | KRYSTAL BIOTECH INC | 481.3K | $178.9M | $162.0M | 3.85% | -- | 2026-06-30 |
| 8 | MAZE | MAZE THERAPEUTICS INC | 5.03M | $150.2M | $121.9M | 2.90% | +465.6K | 2026-06-30 |
| 9 | PHAT | PHATHOM PHARMACEUTICALS INC | 12.47M | $135.3M | $101.7M | 2.42% | -- | 2026-06-30 |
| 10 | PVLA | PALVELLA THERAPEUTICS INC NE | 882.4K | $134.8M | $133.4M | 3.17% | -- | 2026-06-30 |
| 11 | BBIO | BRIDGEBIO PHARMA INC | 1.55M | $115.3M | $105.9M | 2.52% | -1,900,000 | 2026-06-30 |
| 12 | IRON | DISC MEDICINE INC | 1.35M | $99.1M | $91.2M | 2.17% | -- | 2026-06-30 |
| 13 | CYTK | CYTOKINETICS INC | 1.16M | $98.8M | $80.4M | 1.91% | -- | 2026-06-30 |
| 14 | DYN | DYNE THERAPEUTICS INC | 3.15M | $70.0M | $56.4M | 1.34% | -- | 2026-06-30 |
| 15 | ASND | ASCENDIS PHARMA A/S | 225.2K | $60.1M | $54.0M | 1.28% | +91.8K | 2026-06-30 |
| 16 | SVRA | SAVARA INC | 9.72M | $59.9M | $51.1M | 1.22% | -- | 2026-06-30 |
| 17 | PBLS | PARABILIS MEDICINES INC | 1.92M | $52.6M | $68.6M | 1.63% | -- | 2026-06-30 |
| 18 | AURA | AURA BIOSCIENCES INC | 7.10M | $50.4M | $49.1M | 1.17% | +2.00M | 2026-06-30 |
| 19 | ACHV | ACHIEVE LIFE SCIENCE INC | 7.61M | $49.7M | $55.7M | 1.33% | -- | 2026-06-30 |
| 20 | VOR | VOR BIOPHARMA INC | 2.54M | $46.8M | $56.8M | 1.35% | -- | 2026-06-30 |
| 21 | ALLO | ALLOGENE THERAPEUTICS INC | 22.45M | $46.7M | $38.6M | 0.92% | +18.65M | 2026-06-30 |
| 22 | TARS | TARSUS PHARMACEUTICALS INC | 728.6K | $45.9M | $57.0M | 1.36% | -- | 2026-06-30 |
| 23 | BCRX | BIOCRYST PHARMACEUTICALS INC | 4.01M | $40.1M | $32.7M | 0.78% | -- | 2026-06-30 |
| 24 | — | ALKERMES PLC | 700.6K | $36.7M | $36.7M | 0.87% | -- | 2026-06-30 |
| 25 | ACAD | ACADIA PHARMACEUTICALS INC | 1.44M | $36.4M | $38.5M | 0.92% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2